martes, 7 de mayo de 2019

Substandard control arms question some new cancer drugs' utility - STAT

Substandard control arms question some new cancer drugs' utility - STAT

Cancer Briefing

Opinion: Substandard control arms question the utility of some new cancer drugs

By TALAL HILAL


ADOBE
New cancer drugs should be tested against treatments that represent the current standard of care. A new analysis suggests that often doesn't happen.

No hay comentarios: